New data for linagliptin* show clinically meaningful efficacy similar to ... - Financial Post PDF Print
Financial Post
2 Linagliptin was also evaluated in T2D patients with different degrees of renal function. 3 A large pooled analysis of three randomised, placebo-controlled Phase III trials (n=2141) showed that patients who received linagliptin had HbA1c reductions

...

 
Share |
Copyright © 2026 Global Dialysis. All Rights Reserved.

Notice: Undefined variable: query in /home/globaldi/public_html/components/com_joomlawatch/class.joomlawatch.db.php on line 129